Daily Bulletin

Men's Weekly

.

Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial

Highlights:

  • Alterity receives positive guidance from the European Medicines Agency's Committee for Medicinal Products for Human Use on its Phase 2 clinical trial for Multiple System Atrophy.
  • Concurrence with Alterity's plan to target early stage MSA patients.
  • Endorsement on selection of biomarker endpoints to assess pathological hallmarks of MSA.
  • Ag...

Read more: Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2...

Business News

“SMBs Are Building the Future While Australia Sleeps” — Marc Degli on AI, Innovation, and What Needs to Change

Australia’s startup scene has been called “emerging” for a decade — but for many founders, it still feels stalled. Government funding is mired in bureaucracy. Investors hedge their bets on “safe” deal...

Daily Bulletin - avatar Daily Bulletin

Hydrogen Pipe Infrastructure: A Guide to Future Networks

As Australia moves towards a cleaner energy future, hydrogen is emerging as a key player. But how do we get this promising energy source from production facilities to where it's needed? The answer l...

Daily Bulletin - avatar Daily Bulletin

Wang Chuanfu Attends BYD Harmony’s 100th Overseas Store Opening

Dignitaries inaugurate the new store On July 12, 2025, Melbourne, the vibrant pearl of the southern hemisphere, Chairman and President of BYD Co., Ltd. Mr. Wang Chuanfu inaugurated and awarded the ...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals